Melatonin Inhibits Endometriosis Growth via Specific Binding and Inhibition of EGFR Phosphorylation
Journal of Pineal Research · 2024
DOI: 10.1111/jpi.70022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pineal Research, 2024. Verfasst von Yiran Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Melatonin, Endometriosis, ErbB Receptors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was supported by SSFCRS, CUHK, Hong Kong (Grant Nos.: 0670/22) and CMDF, Hong Kong (Grant Nos.: 23B2/034A_R1)..
Abstract (Originalsprache)
As a chronic gynecological disease, endometriosis is defined as the implantation of endometrial glands as well as stroma outside the uterine cavity. Proliferation is a major pathophysiology in endometriosis. Previous studies demonstrated a hormone named melatonin, which is mainly produced by the pineal gland, exerts a therapeutic impact on endometriosis. Despite that, the direct binding targets and underlying molecular mechanism have remained unknown. Our study revealed that melatonin treatment might be effective in inhibiting the growth of lesions in endometriotic mouse model as well as in human endometriotic cell lines. Additionally, the drug–disease protein–protein interaction (PPI) network was built, and epidermal growth factor receptor (EGFR) was identified as a new binding target of melatonin treatment in endometriosis. Computational simulation together with BioLayer interferometry was further applied to confirm the binding affinity. Our result also showed melatonin inhibited the phosphorylation level of EGFR not only in endometriotic cell lines but also in mouse models. Furthermore, melatonin inhibited the phosphatidylinositol‐4,5‐bisphosphate 3‐kinase (PI3K)—protein kinase B (Akt) pathway and arrested the cell cycle via inhibiting CyclinD1 (CCND1). In vitro and in vivo knockdown/restore assays further demonstrated the involvement of the binding target and signaling pathway that we found. Thus, melatonin can be applied as a novel therapy for the management of endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.
- Center for Reproductive Medicine, Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Reproduction and Development, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
- School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.
- Chinese University of Hong Kong-Sichuan University Joint Laboratory in Reproductive Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Förderung
- This study was supported by SSFCRS, CUHK, Hong Kong (Grant Nos.: 0670/22) and CMDF, Hong Kong (Grant Nos.: 23B2/034A_R1).
Zitieren
APA
Li, Y., Hung, S. W., Zheng, X., Ding, Y., Zhang, T., Tan, Z., Zhang, R., Lin, Y., Song, Y., Wang, Y., & Wang, C. C. (2024). Melatonin Inhibits Endometriosis Growth via Specific Binding and Inhibition of EGFR Phosphorylation. Journal of Pineal Research. https://doi.org/10.1111/jpi.70022
Vancouver
Li Y, Hung SW, Zheng X, Ding Y, Zhang T, Tan Z, et al. Melatonin Inhibits Endometriosis Growth via Specific Binding and Inhibition of EGFR Phosphorylation. Journal of Pineal Research. 2024. doi:10.1111/jpi.70022
BibTeX
@article{Li2024,
author = {Li, Yiran and Hung, Sze-Wan and Zheng, Xu and Ding, Yang and Zhang, Tao and Tan, Zhouyurong and Zhang, Ruizhe and Lin, Yuezhen and Song, Yi and Wang, Yao and Wang, Chi-Chiu},
title = {Melatonin Inhibits Endometriosis Growth via Specific Binding and Inhibition of EGFR Phosphorylation},
journal = {Journal of Pineal Research},
year = {2024},
doi = {10.1111/jpi.70022}
}
EUVIMED